BioNTech | Investor Day Presentation Deck

Slide schematic 6/6

diagram 1/1 list 4/4 title 1/1

Components 6

hub-spoke bullet bullet bullet bullet headline

Tools 1

list/bullet: Bulk mRNA: End-to-end production, >100k sq ft, >1B doses, flexible. Modular mRNA / BioNTainer: >50M doses/year, sustainable production. Cell therapy: ~80,000 sq ft, expertise in vectors and CAR-T/TCR. Individualized mRNA: Semi-automated, >1,000 cGMP batches.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

hub-spoke 90%

Central circle connecting four distinct manufacturing capability quadrants.

Find anything

Hub-and-spoke diagram layout showing central infrastructure and four peripheral capability areas.